The Public Health Commission has decided on Tuesday to modify the recommendations in force on third doses in adults with a complete pattern that, subsequently, have suffered Covid-19.
The Commission, formed by responsible for public health from the Autonomous Communities and the Ministry of Health, notes that the interval between the infection and the administration of the dose of memory will be “of a minimum of four weeks” – as I was fixed so far
But with the recommendation that administration is very later, “at five months after the diagnosis of the infection”.
At the beginning of January, the updating of the vaccination strategy set the administration of the third puncture for people between 40 and 65 years with full guideline at least 4 weeks after the diagnosis of the infection.
This space of time had been criticized by specialists in immunology, which considered the waiting period very short before the third dose in cases of infection after the complete pattern.
The new criterion seems to respond to these criticisms and recommends postponing that dose five months after overcoming the infection (and whenever six months of the complete pattern have passed).
“The current evidence shows that the fact of having a SARS-COV-2 infection after having the full primary schedule makes a more powerful and wider immune response develop in terms of neutralizing other variants of the virus, compared to the
Immune response observed in people who only suffered infection or who only received two doses. In addition, omicron infections increase the response of memory cells to viral antigens different from protein s compared to vaccination infections caused by the delta variant
, which implies an extension of immunity, “says the Agreement of the Public Health Commission on the new vaccination strategy, which also establishes clarifications regarding childhood vaccination.
“In the event that the infection of the people between and 11 years occur before the administration of the vaccine, a single dose of the vaccine will be administered from eight weeks after the infection,” the agreement indicates.
In contrast, “if the infection is diagnosed after the first dose, the second dose will be administered from eight weeks after the diagnosis of the infection, maintaining the eight-week interval with respect to the first dose”.
